RAY GERALD L & ASSOCIATES LTD - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAY GERALD L & ASSOCIATES LTD ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$7,506,000
+36.8%
199,260
+1.3%
0.94%
+32.2%
Q2 2017$5,488,000
-13.1%
196,780
+7.1%
0.71%
-18.1%
Q1 2017$6,314,000
+21.4%
183,650
+1.9%
0.86%
+14.6%
Q4 2016$5,199,000
-1.1%
180,280
+9.1%
0.75%
-4.4%
Q3 2016$5,258,000
+1.5%
165,290
+3.6%
0.79%
-4.7%
Q2 2016$5,180,000
+19.4%
159,590
+2.8%
0.83%
+17.8%
Q1 2016$4,339,000
+16.3%
155,190
+48.3%
0.70%
+19.4%
Q4 2015$3,730,000
+10.0%
104,650
+2.1%
0.59%
+4.2%
Q3 2015$3,390,000
-18.2%
102,510
+3.6%
0.56%
-10.5%
Q2 2015$4,144,000
+27.5%
98,950
-0.8%
0.63%
+29.0%
Q1 2015$3,251,000
+4.2%
99,750
+1.5%
0.49%
+1.9%
Q4 2014$3,119,000
+28.8%
98,250
+0.5%
0.48%
+21.8%
Q3 2014$2,422,000
+19.4%
97,800
+8.9%
0.39%
+13.9%
Q2 2014$2,028,000
+6.3%
89,800
+14.6%
0.35%0.0%
Q1 2014$1,907,000
+20.1%
78,350
+23.3%
0.35%
+15.7%
Q4 2013$1,588,000
+24.3%
63,550
+36.5%
0.30%
+13.3%
Q3 2013$1,278,00046,5500.26%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
March Altus Capital Management LP 82,723$2,685,00020.75%
HWG Holdings LP 289,380$9,393,0008.72%
Baker Brothers Advisors 24,516,738$795,813,0008.34%
HARVEY CAPITAL MANAGEMENT INC 352,200$11,432,0005.73%
Belmont Global Advisors, Inc. 150,000$4,869,0004.67%
Palo Alto Investors LP 1,437,730$46,669,0003.52%
Avoro Capital Advisors LLC 329,500$10,696,0002.38%
GARRISON BRADFORD & ASSOCIATES INC 70,100$2,275,0002.23%
WEATHERBIE CAPITAL, LLC 401,642$13,037,0001.85%
ACUTA CAPITAL PARTNERS, LLC 85,999$2,792,0001.34%
View complete list of ACADIA PHARMACEUTICALS INC shareholders